-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Verastem, Lowers Price Target to $13

Benzinga·08/11/2026 11:48:22
Listen to the news
Mizuho analyst Graig Suvannavejh maintains Verastem (NASDAQ:VSTM) with a Outperform and lowers the price target from $14 to $13.